{"AllianceGenome": "6697", "HGNC": "6697", "MIM": "603506", "_id": "4041", "_version": 2, "accession": {"genomic": ["AH010745.2", "AP000807.4", "AP002813.4", "CH471076.1", "CP068267.2", "KF455408.1", "KY436586.1", "KY436587.1", "KY436588.1", "MW302900.1", "MW302901.1", "NC_000011.10", "NC_060935.1", "NG_015835.3"], "protein": ["AAC36467.1", "AAC72791.1", "AAI50596.1", "AAK52433.1", "APX42455.1", "APX42456.1", "APX42457.1", "BAA33051.1", "EAW74705.1", "EAW74706.1", "NP_001278831.1", "NP_002326.2", "O75197.2", "UOK09652.1", "UOK09653.1", "XP_005274051.1", "XP_011543331.1", "XP_011543332.1", "XP_011543333.1", "XP_016873224.1", "XP_016873225.1", "XP_047282904.1", "XP_047282905.1", "XP_047282906.1", "XP_054224760.1", "XP_054224761.1", "XP_054224762.1", "XP_054224763.1", "XP_054224764.1", "XP_054224765.1", "XP_054224766.1", "XP_054224767.1", "XP_054224768.1"], "rna": ["AA279383.1", "AA953315.1", "AB017498.1", "AF064548.1", "AF077820.1", "AF088027.1", "AI583742.1", "BC098397.1", "BC150595.1", "DN999254.1", "MF459052.1", "NM_001291902.2", "NM_002335.4", "XM_005273994.3", "XM_011545029.2", "XM_011545030.2", "XM_011545031.2", "XM_017017735.2", "XM_017017736.2", "XM_047426948.1", "XM_047426949.1", "XM_047426950.1", "XM_054368785.1", "XM_054368786.1", "XM_054368787.1", "XM_054368788.1", "XM_054368789.1", "XM_054368790.1", "XM_054368791.1", "XM_054368792.1", "XM_054368793.1", "XR_001747874.2"], "translation": [{"protein": "XP_054224761.1", "rna": "XM_054368786.1"}, {"protein": "XP_047282904.1", "rna": "XM_047426948.1"}, {"protein": "XP_047282905.1", "rna": "XM_047426949.1"}, {"protein": "NP_002326.2", "rna": "NM_002335.4"}, {"protein": "XP_054224765.1", "rna": "XM_054368790.1"}, {"protein": "XP_011543331.1", "rna": "XM_011545029.2"}, {"protein": "XP_016873225.1", "rna": "XM_017017736.2"}, {"protein": "AAI50596.1", "rna": "BC150595.1"}, {"protein": "BAA33051.1", "rna": "AB017498.1"}, {"protein": "AAC36467.1", "rna": "AF064548.1"}, {"protein": "NP_001278831.1", "rna": "NM_001291902.2"}, {"protein": "XP_054224767.1", "rna": "XM_054368792.1"}, {"protein": "XP_005274051.1", "rna": "XM_005273994.3"}, {"protein": "XP_054224764.1", "rna": "XM_054368789.1"}, {"protein": "XP_054224763.1", "rna": "XM_054368788.1"}, {"protein": "XP_054224760.1", "rna": "XM_054368785.1"}, {"protein": "XP_011543332.1", "rna": "XM_011545030.2"}, {"protein": "AAC72791.1", "rna": "AF077820.1"}, {"protein": "XP_054224766.1", "rna": "XM_054368791.1"}, {"protein": "XP_047282906.1", "rna": "XM_047426950.1"}, {"protein": "XP_016873224.1", "rna": "XM_017017735.2"}, {"protein": "XP_054224762.1", "rna": "XM_054368787.1"}, {"protein": "XP_054224768.1", "rna": "XM_054368793.1"}, {"protein": "XP_011543333.1", "rna": "XM_011545031.2"}]}, "alias": ["BMND1", "EVR1", "EVR4", "HBM", "LR3", "LRP-5", "LRP-7", "LRP7", "OPPG", "OPS", "OPTA1", "PCLD4", "VBCH2"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2023-03-02T17:00:00.000Z", "disease_label": "inherited retinal dystrophy", "gcep": "Retina Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0019118", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c46e0508-399f-48d0-9dbc-55f10cf8460d-2023-03-02T170000.000Z", "sop": "SOP9"}}, "ensembl": {"gene": "ENSG00000162337", "protein": ["ENSP00000294304", "ENSP00000435315", "ENSP00000436652"], "transcript": ["ENST00000294304", "ENST00000528714", "ENST00000528890", "ENST00000529481", "ENST00000529702", "ENST00000529993", "ENST00000533695"], "translation": [{"protein": "ENSP00000294304", "rna": "ENST00000294304"}, {"protein": "ENSP00000436652", "rna": "ENST00000529993"}, {"protein": "ENSP00000435315", "rna": "ENST00000529702"}], "type_of_gene": "protein_coding"}, "entrezgene": "4041", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 44.8638386149, "exp_mis": 830.108610536, "exp_syn": 449.626432303, "lof_z": 5.74760870581096, "mis_z": 3.27831469745039, "mu_lof": 3.29263707449e-06, "mu_mis": 7.58525608394e-05, "mu_syn": 4.12495076549e-05, "n_lof": 6.0, "n_mis": 637.0, "n_syn": 409.0, "p_li": 0.998355570314237, "p_null": 2.44158457138947e-12, "p_rec": 0.00164442968332152, "syn_z": 1.18776874573648}, "bp": 4848, "cds_end": 68216538, "cds_start": 68080182, "n_exons": 23, "nonpsych": {"exp_lof": 40.164792495, "exp_mis": 750.887108161, "exp_syn": 406.514000665, "lof_z": 5.44925686088532, "mis_z": 3.5135888012202, "mu_lof": 3.29263707449e-06, "mu_mis": 7.58525608394e-05, "mu_syn": 4.12495076549e-05, "n_lof": 5.0, "n_mis": 560.0, "n_syn": 379.0, "p_li": 0.998399845280941, "p_null": 1.37674938747551e-11, "p_rec": 0.00160015470529137, "syn_z": 0.859170697445383}, "nontcga": {"exp_lof": 41.2317170074, "exp_mis": 763.656962219, "exp_syn": 413.613321679, "lof_z": 5.4125178167754, "mis_z": 3.20289638073866, "mu_lof": 3.29263707449e-06, "mu_mis": 7.58525608394e-05, "mu_syn": 4.12495076549e-05, "n_lof": 6.0, "n_mis": 586.0, "n_syn": 390.0, "p_li": 0.993886108838372, "p_null": 6.00837176831691e-11, "p_rec": 0.00611389110154438, "syn_z": 0.735159785011797}, "transcript": "ENST00000294304.7"}, "exons": [{"cdsend": 68449070, "cdsstart": 68404358, "chr": "11", "position": [[68312590, 68312805], [68347846, 68348243], [68357649, 68357847], [68363746, 68363943], [68365570, 68365702], [68386315, 68386712], [68403482, 68403699], [68404222, 68404416], [68406523, 68406813], [68409913, 68410140], [68411435, 68411620], [68413688, 68414012], [68416327, 68416527], [68423488, 68423697], [68425101, 68425292], [68425977, 68426187], [68429574, 68429700], [68433601, 68433838], [68436888, 68436999], [68438445, 68438682], [68439776, 68439916], [68446435, 68446533], [68448808, 68449275]], "strand": 1, "transcript": "NM_001291902", "txend": 68449275, "txstart": 68312590}, {"cdsend": 68449070, "cdsstart": 68312714, "chr": "11", "position": [[68312590, 68312805], [68347846, 68348243], [68357649, 68357847], [68363746, 68363943], [68365570, 68365702], [68386315, 68386712], [68389880, 68390052], [68403482, 68403699], [68406523, 68406813], [68409913, 68410140], [68411435, 68411620], [68413688, 68414012], [68416327, 68416527], [68423488, 68423697], [68425101, 68425292], [68425977, 68426187], [68429574, 68429700], [68433601, 68433838], [68436888, 68436999], [68438445, 68438682], [68439776, 68439916], [68446435, 68446533], [68448808, 68449275]], "strand": 1, "transcript": "NM_002335", "txend": 68449275, "txstart": 68312590}], "exons_hg19": [{"cdsend": 68216538, "cdsstart": 68171826, "chr": "11", "position": [[68080058, 68080273], [68115314, 68115711], [68125117, 68125315], [68131214, 68131411], [68133038, 68133170], [68153783, 68154180], [68170950, 68171167], [68171690, 68171884], [68173991, 68174281], [68177381, 68177608], [68178903, 68179088], [68181156, 68181480], [68183795, 68183995], [68190956, 68191165], [68192569, 68192760], [68193445, 68193655], [68197042, 68197168], [68201069, 68201306], [68204356, 68204467], [68205913, 68206150], [68207244, 68207384], [68213903, 68214001], [68216276, 68216743]], "strand": 1, "transcript": "NM_001291902", "txend": 68216743, "txstart": 68080058}, {"cdsend": 68216538, "cdsstart": 68080182, "chr": "11", "position": [[68080058, 68080273], [68115314, 68115711], [68125117, 68125315], [68131214, 68131411], [68133038, 68133170], [68153783, 68154180], [68157348, 68157520], [68170950, 68171167], [68173991, 68174281], [68177381, 68177608], [68178903, 68179088], [68181156, 68181480], [68183795, 68183995], [68190956, 68191165], [68192569, 68192760], [68193445, 68193655], [68197042, 68197168], [68201069, 68201306], [68204356, 68204467], [68205913, 68206150], [68207244, 68207384], [68213903, 68214001], [68216276, 68216743]], "strand": 1, "transcript": "NM_002335", "txend": 68216743, "txstart": 68080058}], "generif": [{"pubmed": 11741193, "text": "mutation results in an autosomal dominant high-bone-mass trait"}, {"pubmed": 11793484, "text": "seven novel sequence variants/polymorphisms"}, {"pubmed": 12015390, "text": "The LRP5V171 mutation causes high bone density by impairing the action of a normal antagonist of the Wnt pathway and thus increasing Wnt signaling. These findings demonstrate the role of altered LRP5 function in high bone mass."}, {"pubmed": 12054167, "text": "localization to chromosome 11q12-13 in autosomal dominant osteopetrosis type I"}, {"pubmed": 12579474, "text": "Six novel missense mutations in this gene shown in various conditions with an increased bone density and bone diseases."}, {"pubmed": 12700977, "text": "disease association data, largely focused in the LRP5 region with 1,106 type 1 diabetes families, provided no further evidence for disease association at LRP5 or at D11S987"}, {"pubmed": 12817748, "text": "G171V transgenic mice showed an increase in actively mineralizing bone surface and enhanced alkaline phosphatase staining in osteoblasts"}, {"pubmed": 14727154, "text": "LRP5 is a bone mineral density determinant and also contributes to a risk of osteoporosis"}, {"pubmed": 14727154, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14735475, "text": "LRP5 has a role in neoplasm metastasis"}, {"pubmed": 15024691, "text": "Familial exudative vitreoretinopathy has mutations in a second gene at the EVR1 locus, low-density-lipoprotein receptor-related protein 5 (LRP5), a Wnt coreceptor"}, {"pubmed": 15077203, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15201508, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15201508, "text": "no association was found between a LRP5 polymorphism and peak bone mass in young men"}, {"pubmed": 15221492, "text": "LRP5 gene is a candidate for the genetic determinants of bone mineral density in postmenopausal women"}, {"pubmed": 15221492, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15346351, "text": "Mutations in LRP5 can cause autosomal recessive or dominant Familial exudative vitreoretinopathy."}, {"pubmed": 15355556, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15619672, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15777745, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15777745, "text": "genetic variation in LRP5 seems to be of importance for regulation of bone mass and osteoporotic fractures"}, {"pubmed": 15781005, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15824851, "text": "heterozygous mutations in the LRP5 gene can cause osteoporosis in both children and adults"}, {"pubmed": 15824861, "text": "a novel LRP5 mutation may be responsible for oropharyngeal skeletal disease"}, {"pubmed": 15908424, "text": "SOST antagonizes Wnt signaling by binding to the extracellular domain of the Wnt coreceptors LRP5 and LRP6 and disrupting Wnt-induced Frizzled-LRP complex formation."}, {"pubmed": 15923613, "text": "These data suggest that HBM mutant proteins can transit to the cell surface in sufficient quantity to transduce Wnt signal and that the likely mechanism for the HBM mutations' physiologic effects is via reduced affinity to and inhibition by DKK1."}, {"pubmed": 15979013, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15981244, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 15981244, "text": "mutations in the LRP5 and/or FZD4 genes may have roles in familial exudative vitreoretinopathy"}, {"pubmed": 16115379, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16168727, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16168727, "text": "These data indicate an association between LRP5 variants and idiopathic osteoporosis in males, pointing to a role of LRP5 in this disease."}, {"pubmed": 16234968, "text": "Carrying an LRP5 mutation is a risk factor for idiopathic osteoporosis, but idiopathic osteoporosis in men is infrequently underlied by such a mutation."}, {"pubmed": 16355283, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 16513652, "text": "active CKIepsilon generation may induce a negative feedback loop by phosphorylation of sites on LRP5/6 that modulate axin binding and hence beta-catenin degradation"}, {"pubmed": 16613987, "text": "Lrp5 locus was discovered to confer vitamin D response to a heterologous promoter when introduced into osteoblastic cells"}, {"pubmed": 16622736, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16631011, "text": "LRP5 was increased in the calcified aortic valves by protein and gene expression."}, {"pubmed": 16679074, "text": "observed mutations may affect the molecular interactions of LRP5 and so lead to the observed osteoporosis pseudoglioma syndrome phenotypes"}, {"pubmed": 16723389, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16754270, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16754270, "text": "The Q89R polymorphism is an independent factor for hypertension in Japanese females."}, {"pubmed": 16772034, "text": "Splice forms of crucial genes of the Wnt-pathway, beta-Catenin, LRP5, GSK3beta, Axin-1 and CtBP1 are expressed in human colorectal tissue."}, {"pubmed": 16956801, "text": "This study examined human LRP5 signaling and the effects of an intracellular domain single nucleotide polymorphism (SNP: p.V1525A) on osteoblast differentiation and mineralization."}, {"pubmed": 16958596, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17002572, "text": "functional interactions between Sost or Wise and LRP5 have the potential to regulate bone deposition by modulating Wnt signaling"}, {"pubmed": 17052975, "text": "SOST-LRP5 antagonistic interaction plays a central role in bone mass regulation and may represent a nodal point for therapeutic intervention for osteoporosis and other bone diseases"}, {"pubmed": 17086708, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17087607, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17087607, "text": "we found a relationship between the LRP5 genotype and serum follicle stimulating hormone but not luteinizing hormone levels"}, {"pubmed": 17137849, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17137849, "text": "Wnt-LRP5 signalling may play a role in the adaptation of bone to mechanical load in humans, and may explain some gender-related differences in bone mass"}, {"pubmed": 17202888, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17223614, "text": "In comparison with subjects with the AlaAla genotype (n=215), those with AlaVal genotype (n=20) had lower femoral neck BMC (P=0.029) and BMD (P=0.012), trochanter BMC (P=0.0067) and BMD (P=0.015), and total hip BMC (P=0.0044) and BMD (P=0.0089)."}, {"pubmed": 17229572, "text": "1,25(OH)(2)D(3) can enhance the expression of a critical component of the Wnt signaling pathway which is known to impact osteogenesis"}, {"pubmed": 17241106, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17276019, "text": "Results indicate the importance of LRP5 beta-propeller 1 for Dkk1 function and Wnt signaling."}, {"pubmed": 17306638, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17306638, "text": "genetic variations in LRP5 are important factors affecting BMD in adult women, and 1330 V may contribute to osteoporosis susceptibility, at least in Japanese"}, {"pubmed": 17307038, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17307038, "text": "Premenopausal women drove the association as expected from the proposed role of LRP5 in peak bone mass"}, {"pubmed": 17505772, "text": "LRP5 polymorphism effect on bone mineral density is apparent in childhood"}, {"pubmed": 17505772, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17680723, "text": "LRP5 mutations and the level of Wnt signaling determine differentiation fate of hMSCs into osteoblasts or adipocytes."}, {"pubmed": 17700537, "text": "concludes that bone-derived prostate cell line that produces osteoblastic lesions induces new bone formation through Wnt canonical signaling, that LRP5 mediates this effect, and that DKK1 is involved in the balance between bone formation and resorption"}, {"pubmed": 17953969, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17972053, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 18026682, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18044981, "text": "an internally truncated LRP5 receptor is strongly implicated in deregulated activation of the WNT/beta-catenin signaling pathway in hyperparathyroid tumors"}, {"pubmed": 18058054, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18058054, "text": "The Ala1330Val and Val667Met polymorphisms in the low-density lipoprotein receptor-related protein 5 gene are significantly associated with peak bone mass in physically active men."}, {"pubmed": 18073493, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18073493, "text": "Single nucleotide polymorphisms of the LRP5 promoter are associated with bone mineral density variation in young Chinese females"}, {"pubmed": 18285546, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18349089, "text": "LRP5 may be the first gene to reach a genome-wide significance level for a phenotype related to osteoporosis."}, {"pubmed": 18349089, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18406176, "text": "No association was seen between FRZB, LRP5 and LRP6 variants with radiographic osteoarthritic outcomes in two population-based cohorts"}, {"pubmed": 18406176, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18418639, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18418639, "text": "The association between LRP5 V667M and LS BMD is confirmed but not that between ESRRA repeats and LS BMD."}, {"pubmed": 18455228, "text": "Genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18455228, "text": "Two gene variants of key biological proteins increase the risk of osteoporosis and osteoporotic fracture."}, {"pubmed": 18493104, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18493104, "text": "We found no evidence for a substantial effect of LRP5 or LRP6 SNPs on susceptibility to type 2 diabetes or clinical characteristics of diabetic subjects in Japanese population."}, {"pubmed": 18502762, "text": "Kremen may not be essential for Dkk1-mediated Wnt antagonism and Kremen may only play a role when cells express a high level of LRP5/6"}, {"pubmed": 18521528, "text": "DKK1 and sclerostin are independent, and not synergistic, regulators of LRP5 signaling and that the function of each is impaired by HBM-LRP5 mutations"}, {"pubmed": 18524778, "text": "analysis of the structural basis of the interaction between Dkk and low density lipoprotein receptor-related protein (LRP) 5/6"}, {"pubmed": 18588671, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18588671, "text": "there is a modest effect of the A1330V polymorphism on BMD in the general population, and that the modest association may limit its clinical use"}, {"pubmed": 18676680, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18684085, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18684085, "text": "analysis of LRP5 haplotypes in relation to osteoporosis phenotypes in Spanish postmenopausal women"}, {"pubmed": 18721193, "text": "Genetic variation in LRP5 did not predispose to premature adrenarche but was associated with metabolic characteristics, especially lipid profile, in healthy prepubertal children."}, {"pubmed": 18721193, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18825883, "text": "Follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation."}, {"pubmed": 18932002, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18932002, "text": "This meta-analysis shows that LRP5 A1330V polymorphism is associated with bone density, and that individuals with the AA genotype have a higher bone density than those with the AV/VV or VV genotype."}, {"pubmed": 19023643, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19023643, "text": "results suggest that the LPR5 polymorphism does not appear to be a clinically useful marker for the prediction of fracture risk in Japanese female rheumatoid arthritis patients, although it is associated with increased serum total cholesterol levels."}, {"pubmed": 19107203, "text": "Phosphorylated LRP6/5 both recruits and directly inhibits GSK3beta using two distinct portions of its cytoplasmic sequence."}, {"pubmed": 19147944, "text": "This review finds that LRP5 and LRP6 play overlapping roles in both early and late stages of osteoblast differentiation."}, {"pubmed": 19148563, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19148563, "text": "the LRP5 A1330V polymorphism is associated with hip bone mineral density in osteoporotic men, but allelic variations in LRP5 do not appear to be associated with response to bisphosphonate treatment."}, {"pubmed": 19158955, "text": "the LRP5Delta receptor is strongly implicated in mammary gland tumorigenesis"}, {"pubmed": 19170196, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19177549, "text": "identifying two novel types of mutation in related individuals whose presenting features were profound muscle hypotonia, mild mental retardation, blindness, and growth retardation"}, {"pubmed": 19225709, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19225709, "text": "The geometric dimensions of the proximal femur in perimenopausal women are not associated with LRP5 polymorphism."}, {"pubmed": 19233690, "text": "Gene Ontology analysis indicated a significant alteration of oxygen transport (increased hemoglobin gene expression) and lipid metabolism [including monoglyceride lipase and low density lipoprotein receptor-related protein 5 (LRP5) gene]."}, {"pubmed": 19336475, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19453261, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19506792, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19571442, "text": "association between the A1330V SNP and total body BMD were replicated in 739 postmenopausal Japanese women (AA vs. VV; P = 0.0026). These data suggest that the V1330 variant in the LRP5 gene decreases Wnt activity, which in turn decreases the BMD."}, {"pubmed": 19625176, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19629617, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19673927, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19673927, "text": "We found high prevalence of osteoporosis and abnormal glucose metabolism in subjects with LRP5 mutation(s)."}, {"pubmed": 19692168, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19746449, "text": "a high bone mass mutant LRP5(G171V), has subtly reduced Dkk1 binding, and, in contrast to LRP5, no enhancement of binding with MesD"}, {"pubmed": 19789208, "text": "Increased LRP5 polymorphisms may contribute to bone mass accrual in prepubertal premeture adrenarche children."}, {"pubmed": 19810105, "text": "Catabolic role of LRP5 may be mediated by Wnt/beta-catenin pathway in human osteoarthritis."}, {"pubmed": 19851296, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19898734, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19898734, "text": "results suggest that A1330V in LRP5, is not associated with bone mineral density in the Slovenian population"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19948975, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and genetic testing. (HuGE Navigator)"}, {"pubmed": 20034086, "text": "found various types of LRP5 mutations, including an exon-level deletion that is undetectable by standard PCR-based mutation screening. Oligonucleotide tiling microarray seems to be a powerful tool in identifying cryptic structural mutations"}, {"pubmed": 20045498, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20045498, "text": "Our study shows that in children LRP5 mutations are not a common cause of increased fractures."}, {"pubmed": 20101398, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20141633, "text": "Both Kruppel-like factor 15 and specificity protein 1 binding motifs are essential for human LRP5 promoter activity."}, {"pubmed": 20146170, "text": "Evidence of an allele of LRP5 in Chinese increases the total cholesterol level in a general Han population."}, {"pubmed": 20146170, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20198315, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20200960, "text": "circulating serotonin levels mediate the increased bone mass resulting from gain-of-function mutations in Lrp5 in humans"}, {"pubmed": 20200978, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20534768, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20554715, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20613673, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20630166, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20630166, "text": "These findings demonstrate that both LRP5 polymorphism and its interaction with calcium intake are associated with BMD, whereas higher calcium intake was shown to decrease the negative effect of this polymorphism on BMD"}, {"pubmed": 20846389, "text": "The mRNA expression levels of DKK-1 binding receptor LRP5/6 and Krm1/2 in SCs from patients with MM were significantly higher than those in myeloma cells and in SCs from healthy donors."}, {"pubmed": 20926594, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20926594, "text": "We found common polymorphisms of LRP5 associated with osteoporotic fractures, and polymorphisms of the LRP6 gene associated with BMD, thus suggesting them as likely candidates to contribute to the explaination of the hereditary influence on osteoporosis."}, {"pubmed": 20953208, "text": "Common polymorphic variations of the LRP5 gene do not influence peak bone mass acquisition and obesity phenotypes in young Chinese men."}, {"pubmed": 20953208, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20960157, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20961463, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 21116122, "text": "association of Ala1330Val and Val667Met polymorphisms in LRP5 with volumetric BMD and macro-architectural bone parameters in a population-based sample of men and women"}, {"pubmed": 21147715, "text": "LRP5 gene was stronly associated with the BMD in Europeans and North Americans."}, {"pubmed": 21351148, "text": "Increased bone mass in Lrp5-high bone mass patients seems to be caused primarily by changes in trabecular and cortical bone mass and structure."}, {"pubmed": 21397183, "text": "Two structural and functional domains of MESD required for proper folding and trafficking of LRP5/LRP6."}, {"pubmed": 21407258, "text": "Study present clinical and genetic data for four Osteoporosis-pseudoglioma sydrome patients with novel LRP5 mutations, three of which affect splicing"}, {"pubmed": 21432225, "text": "Analysis of variance and post hoc Tukey test indicated that mean bone mass density was significantly lower in subjects with VV genotype than in those with AA genotype (0.540 +/- 0.048 versus 0.562 +/- 0.062 g/cm(2))."}, {"pubmed": 21471826, "text": "The LRP5 c.266A > G and c.3893C > T polymorphisms may be associated with risk of nonresponse to hormone therapy in postmenopausal Korean women."}, {"pubmed": 21528003, "text": "The LRP5.Q89R polymorphism did not change protein expression, interaction with the molecular chaperone MESD, protein trafficking, Wnt signaling transduction, or its efficacy in DKK1-mediated inhibition."}, {"pubmed": 21542013, "text": "This is the first time that the direct action of RUNX2 on LRP5 has been described."}, {"pubmed": 21774378, "text": "SNP (IVS17-1677C>A) located in intron 17 of LRP5 has effects on bone density of postmenopausal Japanese women.[review]"}, {"pubmed": 21821287, "text": "LRP5 gene rearrangement in 11q13.2 is associated with acute myeloid leukemia."}, {"pubmed": 21840657, "text": "These findings demonstrate that the A1330V and V667M polymorphisms are associated with low bone mineral density in peri- and postmenopausal Greek women."}, {"pubmed": 21885484, "text": "Data suggest that LRP5 may be involved in the pathogenesis of ankylosing spondylitis."}, {"pubmed": 21887268, "text": "These studies uncover a new and important molecular tuning mechanism for differential regulation of LRP5 and LRP6 phosphorylation and signaling activity."}, {"pubmed": 22000856, "text": "The LRP5 is a coreceptor for Wnt growth factors, and also bind Dkk proteins, secreted inhibitors of Wnt signaling."}, {"pubmed": 22167346, "text": "These results suggest that LRP5 alleles influence the type of hip fractures"}, {"pubmed": 22207519, "text": "osteosarcoma patients whose primary tumors expressed LRP-5 sustained a higher risk of developing metastasis"}, {"pubmed": 22303459, "text": "LRP5 oligomerization results in its localization to disheveled-containing punctate structures and sequestration of scaffold protein Axin, leading to robust beta-catenin-mediated signaling."}, {"pubmed": 22487062, "text": "Two novel LRP5 mutations (c.3446 T > A; p.L1149Q and c.3553 G > A; p.G1185R) were identified in two patients and their affected family members."}, {"pubmed": 22513174, "text": "Wnt/beta-catenin signaling activation through LRP-5 may contribute to chondrocyte hypertrophy and cartilage degradation in osteoarthritis."}, {"pubmed": 22589387, "text": "Crystal structures of the LRP6 ectodomain in complex with DKK1, along with mutagenesis studies, provide considerable insights into the molecular basis for DKK-mediated inhibition and Wnt signaling through LRP5/6"}, {"pubmed": 22696217, "text": "peptide derived from the loop 2 region of sclerostin blocked the interaction of sclerostin with LRP5/6 and also inhibited Wnt1 but not Wnt3A or Wnt9B signaling. This suggests that these Wnts interact with LRP6 in different ways"}, {"pubmed": 22848540, "text": "LRP5-Tie2-Ang signaling axis plays a central role in control of both angiogenesis and alveolarization during postnatal lung development"}, {"pubmed": 23041840, "text": "Six Dkk-1, three Sost, one Kremen-1 and 10 LRP-5 polymorhpisms were significantly associated with radiological progression of rheumatoid arthritis joint destruction."}, {"pubmed": 23054017, "text": "Demonstration of the additive effect of four polymorphisms on the LRP5, LEPR, near MC4R and SH2B1 genes on metabolic syndrome risk."}, {"pubmed": 23077402, "text": "Six mutations have been found in the LRP5 gene in five Chinese families with familial exudative vitreoretinopathy."}, {"pubmed": 23238007, "text": "LRP5 and FDPS loci age-specifically affect skeletal traits in healthy fertile women."}, {"pubmed": 23242660, "text": "Our results supported the association of LRP5 with osteoporosis and showed the potential value of LRP5 haplotypes to identify risk of osteoporosis in Mexican population."}, {"pubmed": 23318847, "text": "In this osteosclerotic Chinese family, the A242T mutation in the LRP5 gene results in a high bone mass phenotype with an elongated mandible and torus palatinus in the center of the hard palate."}, {"pubmed": 23441120, "text": "Six different nonsynonymous DNA variants in are identified in the coding region of either the FZD4 gene (p.H69Y, p.R127H, and p.Y211H) or the LRP5 gene (p.R1219H, p.H1383P, and p.T1540M) in seven patients with advanced retinopathy of prematurity"}, {"pubmed": 23490293, "text": "Identify rs4988300 and rs3781590 LPR5 polymorphisms as independent genetic markers of abdominal aortic aneurysms."}, {"pubmed": 23800666, "text": "Studies indicate that splice site mutation that leads to aberrant splicing often causes genetic skeletal system disease, like COL1A1, SEDL and LRP."}, {"pubmed": 24130145, "text": "The Val genotype of the rs3736228 (p.A1330V) of LRP5 was significantly associated with bone mineral density (BMD) variations at the lumbar spine, total hip, and femoral neck. None of the three polymorphisms of TNFRSF11B was associated with BMD variations."}, {"pubmed": 24266894, "text": "LRP5 negatively regulates differentiation of monocytes through abrogation of Wnt signaling."}, {"pubmed": 24337955, "text": "These results underscore the significance of the LRP5 gene in bone metabolism and emphasize the significance of the replication of previous results in independent cohorts."}, {"pubmed": 24376863, "text": "LRP5 polymorphisms may be modestly associated with bone mineral density of the lumbar spine and the femur neck."}, {"pubmed": 24403228, "text": "LRP5 plays a role in prostate cancer invasion growth and skeletal metastasis in vitro and in vivo."}, {"pubmed": 24412065, "text": "GSK3 is sequestered into multivesicular bodies through and interaction between p120-catenin/cadherin and LRP5/6."}, {"pubmed": 24479426, "text": "Our findings indicate that LRP5 plays an essential role in osteoarthritis cartilage destruction"}, {"pubmed": 24606091, "text": "Circulating plasma sclerostin concentrations are increased in both LRP5 and non-LRP5 High bone mass patients compared with controls."}, {"pubmed": 24706814, "text": "Functional activity analyses indicated that mutant LRP5 led to reduced wingless signal activation"}, {"pubmed": 24715757, "text": "Two new novel LRP5 mutations in Chinese patients with familial exudative vitreoretinopathy and mild reduced bone mineral density, were identified."}, {"pubmed": 24736728, "text": "evidence of lack of LRP5 mutations and of a putative HBM-causing mutation in DKK1"}, {"pubmed": 24743782, "text": "The results suggested that the lack of affinity between human DKK3 and human LRP5/6 results from: i) insertion of the 7 amino acids, and ii) P258 in human DKK3."}, {"pubmed": 24885293, "text": "The Ala1330Val polymorphism in LRP5 is weakly associated with lower lumbar spine bone density in Tunisian post-menopausal women."}, {"pubmed": 24897288, "text": "The A1330V polymorphism of LRP5 is possibly correlated with response to alendronate treatment in Chinese women."}, {"pubmed": 24921217, "text": "The Wnt coreceptor, Lrp5, is a genetic driver of lung fibrosis in mice and a marker of disease progression and severity in humans with idiopathic pulmonary fibrosis."}, {"pubmed": 24927689, "text": "Serum levels of Wnt inhibitors are not changed in individuals with high bone mass causing mutations in LRP5."}, {"pubmed": 25329009, "text": "Independently or combined with APOE, LRP5 polymorphisms may lead to dyslipidemia and are associated with generalized aggressive periodontitis. Dyslipidemia may be a risk indicator for generalized aggressive periodontitis in the Chinese population. Furthermore, two LRP5 polymorphisms (rs682429 and rs312016) might be useful for identifying subjects at higher risk of generalized aggressive periodontitis."}, {"pubmed": 25384351, "text": "Although AFFs have been reported in other rare bone diseases, this is the first in a genetic condition of primary osteoblast dysfunction. The relatively low bone turnover observed, and knowledge of LRP5 function"}, {"pubmed": 25392953, "text": "This is the first study to suggest the genetic influence of LRP5 A1330V polymorphism on bone mineral density in COPD patients, independent of the development of emphysema."}, {"pubmed": 25515155, "text": "This study show LRP5 polymorphism may associate with body composition and bone mineral density in Iranian children."}, {"pubmed": 25580429, "text": "These results suggest that there is a modest effect of the LRP5 rs3736228 C>T on the increased susceptibility of bone fracture and osteoporosis."}, {"pubmed": 25651180, "text": "Reciprocally, a low bone mineral density-associated common LRP5 allele correlated with increased abdominal adiposity."}, {"pubmed": 25762437, "text": "finding corroborates the relationship between LRP5 genotype and bone phenotype in postmenopausal women, however, the complete mechanism of this relationship requires further investigations."}, {"pubmed": 25783012, "text": "No mutations in LRP5 and LRP6 could be identified"}, {"pubmed": 25863010, "text": "no association of single nucleotide polymorphisms and type 2 diabetes mellitus susceptibility in Chinese population"}, {"pubmed": 25902418, "text": "Lrp5 binds to Frizzled, preventing Frz-regulated non-canonical Wnt pathway activation and further non-canonical pathway-mediated tumour metastasis."}, {"pubmed": 25920554, "text": "we identified a total of four different LRP5 variants that were predicted to be pathogenic by in silico tools. One ADPKD patient has a positive family history for ADPKD and variant LRP5 segregated with the disease."}, {"pubmed": 25945592, "text": "Molecular testing identified biallelic lipoprotein receptor-related protein 5 (LRP5) mutations (NM_002335.3:c. [889dupA]; [2827 + 1G > A]) confirming a diagnosis of osteoporosis-pseudoglioma (OPPG) syndrome."}, {"pubmed": 25959626, "text": "findings suggest that rescuing LRP5/6-mediated Wnt signaling improves neuronal cell survival and reduces tau phosphorylation, which support the hypothesis that Wnt signaling might be an attractive therapeutic strategy for managing AD"}, {"pubmed": 26117992, "text": "mechanism of LRP protein action in the process of bone tissue metabolism and etiology of osteoporosis."}, {"pubmed": 26244290, "text": "Among the patients with pathogenic mutations detected, FZD4 mutations accounted for the largest proportion of autosomal inheritance FEVR cases (13/18 patients, 72.2%), followed by LRP5 (4/18 patients, 22.2%) and TSPAN12 (1/18 patients, 5.6%)."}, {"pubmed": 26248735, "text": "No LRP5 variant was found to be associated with type 2 diabetes mellitus in Han Chinese, but haplotype TT was found to be associated with type 2 diabetes mellitus ."}, {"pubmed": 26666179, "text": "LRP5 is a signature of the anti-inflammatory defensive phenotype of macrophages."}, {"pubmed": 26681532, "text": "Data show that LDL receptor-related protein 5 (LRP5) gain-of-function mutations do not activate beta-catenin signaling in osteoblasts."}, {"pubmed": 26711269, "text": "Lrp5 controls glucose uptake and growth of MDA-MB-231 human breast cancer cells."}, {"pubmed": 26739212, "text": "LRP5 is a novel anti-inflammatory macrophage marker that positively regulates migration, phagocytosis, lipid uptake and metabolism."}, {"pubmed": 26774446, "text": "miR-23a plays an inhibitory role in osteogenic differentiation of hBMSCs, which may act by targeting LRP5"}, {"pubmed": 27007396, "text": "The authors report a case of familial exudative vitreoretinopathy in the spectrum of osteoporosis pseudoglioma syndrome associated with novel mutations of the LRP5 and TSPAN12 genes that resulted in a phenotype similar to bilateral persistent fetal vasculature."}, {"pubmed": 27051030, "text": "Meta-analysis indicates that the LRP5 Ala1330Val polymorphism may not be correlated with fracture susceptibility."}, {"pubmed": 27228167, "text": "We identified four novel LRP5 missense mutations in these FEVR families: c.C1042T (p.R348W), c.G1141A (p.D381N), c.C1870T (p.R624W), and c.A4550G (p.Y1517C). All four of these LRP5 mutations led to significant reduction of enzymatic activity with response to NORRIN. Our findings expand the mutational spectrum of FEVR in the Indian population and provide some guidelines in clinical diagnosis."}, {"pubmed": 27486893, "text": "A genetic evaluation of the known genes associated with familial exudative vitreoretinopathy (FEVR) revealed a novel variant in the LRP5 gene that co-segregated with the phenotype in the family."}, {"pubmed": 27582019, "text": "This study did not identify LRP5 polymorphisms as a risk factor for osteoporosis in Thai menopausal women."}, {"pubmed": 27821587, "text": "findings revealed an unrecognized role of Caprin-2 in facilitating LRP5/6 constitutive phosphorylation at G2/M through forming a quaternary complex with CDK14, Cyclin Y, and LRP5/6."}, {"pubmed": 28028632, "text": "LRP5 might be an important genetic marker contributing to bone mass accrual early in life."}, {"pubmed": 28067456, "text": "Data suggest that the risk of type 2 diabetes mellitus (T2DM) may be associated with interactions between the low-density lipoprotein receptor-related protein 5 (LRP5) gene and overweight and obesity."}, {"pubmed": 28111184, "text": "In this study, the splice site mutation c.2827thorn1G > A found in LRP5 (603506) gene is thought to cause microphthalmia in this family."}, {"pubmed": 28139941, "text": "LRP5 (rs556442) had a significant influence on trigylceride (TG) levels in unadjusted analysis and when adjusted for interacting factors. Higher TG levels were observed in AA/AG genotype of rs566442 in comparison to GG genotype (OR = 2.028, 95% CI = 0.997-4.127, p = 0.049)."}, {"pubmed": 28145787, "text": "To our knowledge, these are the first two cases of the syndrome described in Italy. Genetic testing proved to be fundamental for definition of the syndrome and confirms the importance of early detection of LRP5 variants for management of systemic features of the disease in patients and carrier relatives."}, {"pubmed": 28283687, "text": "The data do not support the hypothesis that HBM-causing LRP5 mutations, associated with increased Wnt signaling, improve glucose metabolism in humans. However, it does appear that LRP5 variants may affect LDL metabolism, a major risk factor for coronary artery disease."}, {"pubmed": 28420620, "text": "wild-type and all five mutant LRP5 proteins were assayed for the ability to activate the Norrin/beta-catenin pathway by established luciferase reporter assays, and all mutants failed to activate the pathway."}, {"pubmed": 28425175, "text": "VAP1 cleaved the extracellular region of LRP5. This cleavage removes four inhibitory beta-propeller structures, resulting in activation of LRP5/6."}, {"pubmed": 28494495, "text": "Among the detected mutations, LRP5 accounted for the largest proportion with a mean mutation rate of 16.1% (5/31, 16.1%), followed by NDP (3/31, 9.7%), FZD4 (2/31, 6.5%), TSPAN12 (1/31, 3.2%), and KIF11 (1/31, 3.2%). All the novel changes were predicted to be pathogenic by a series of bioinformatics analyses."}, {"pubmed": 28677207, "text": "In conclusion, the LRP5 mutation influences cell proliferation through the Wnt signaling pathway, thereby reducing the number of supporting cells and hair cells and leading to nonsyndromic hearing loss in this Chinese family."}, {"pubmed": 28867931, "text": "We identified two novel heterozygous deletion mutations [LRP5, c.4053 DelC (p.Ile1351IlefsX88); TSPAN12, EX8Del] using targeted NGS as a causative mutation for Familial exudative vitreoretinopathy (FEVR)."}, {"pubmed": 28893644, "text": "A novel heterozygous mutation (p.N198Y) in LRP5 was identified in a patient with significantly increased bone mineral density."}, {"pubmed": 28973524, "text": "The presence of GIIA in the LRP5 complex pinpoints a potential functional connection with PRKCSH. Interestingly, all three PLD-associated protein complexes included filamin A (FLNA), a multifunctional protein described to play a role in ciliogenesis as well as canonical Wnt signalling."}, {"pubmed": 29038835, "text": "An interaction was found between LRP5 SNP rs648438 and periostin SNP rs9547970 on serum periostin levels and on radial cortical porosity."}, {"pubmed": 29131652, "text": "Phenotypic variability was observed in the familial case and molecular analysis identified a novel homozygous c.1145C>T, p.(Pro382Leu) variant in both sibs. Homozygosity for the c.442C>T, p.(Gln148*) variant was also demonstrated in a separate case."}, {"pubmed": 29181528, "text": "The detection rate for mutations in the three known genes was 23%. Mutations in LRP5 and TSPAN12 were more frequent, accounting for 10% and 8%"}, {"pubmed": 29207047, "text": "These findings expand the mutation spectrums of ABCA4 and LRP5, and will be valuable for genetic counseling and development of therapeutic interventions for patients with Familial exudative vitreoretinopathy."}, {"pubmed": 29208525, "text": "We present two members of a family with a novel LRP5 mutation associated with high bone mass."}, {"pubmed": 29594386, "text": "Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2."}, {"pubmed": 29963786, "text": "Our results suggest that the Val667Met LRP5 (rs312009) polymorphism may contribute to an elevated risk for fractures in postmenopausal Polish women."}, {"pubmed": 30019084, "text": "Significant associations between LRP5 SNPs (p.A1330V, p.N740N, and p.V667M) and the severity of radiographic damage reinforce the evidence of bone destruction heritability in rheumatoid arthritis."}, {"pubmed": 30097784, "text": "This is the first study to report a group of patients with digenic familial exudative vitreoretinopathy (FEVR). In most affected eyes, the stage was more severe than stage 3. We speculate that the phenotype of FEVR is more severe in patients with digenic rather than monogenic variants of FEVR-related genes."}, {"pubmed": 30304114, "text": "our results demonstrated an association of the T allele for the LRP5 4037C>T polymorphism with type 1 diabetes mellitus susceptibility in a Brazilian population, moreover the possible relation in the progressive failure of glycemic control."}, {"pubmed": 30305727, "text": "the crosstalk between Hsp90ab1 and LRP5 contributed to the upregulation of multiple mesenchymal markers, which are also targets of Wnt/beta-catenin. Collectively, this study uncovers the details of the Hsp90ab1-LRP5 axis, providing novel insights into the role and mechanism of invasion and metastasis in gastric cancer (GC) ."}, {"pubmed": 30361437, "text": "oligomerizations of FZDs and LRP5/6 can integrate the cytoplasmic protein Dishevelled into the LRP5/6 signalosome, resulting in a robust activation of ligand-independent beta-catenin signaling"}, {"pubmed": 30404864, "text": "loss of Lrp5, the co-receptor thought to transmit extracellular WNT signals during bone mass regulation, did not reduce the bone-anabolic effect of Wnt1, providing direct evidence that Wnt1 function does not require the LRP5 co-receptor."}, {"pubmed": 30474181, "text": "association of LRP5 intronic rs4988319 and rs3736228 (Ala1330Val) with attention deficit and hyperactivity disorder (cADHD) was observed among girls, whereas in boys association between LRP6 rs2302685 (Val1062Ile) and cADHD was present (OR = 1.66, CI = 1.20-2.31, p = .0024).  In the PGC-ADHD dataset tendency of associations were observed only among females for LRP5 rs3736228 and for LRP6 rs2302685."}, {"pubmed": 30499050, "text": "The genetic and clinical phenotype of 10 new osteoporosis-pseudoglioma syndrome (OPPG) patients is reported. Mutational screening of LRP5 gene revealed the c.2409_2503+79del deletion in homozygous state, expected to result in a truncated protein. Among 44 members of the pedigree, 10 were identified homozygous and 34 heterozygous. The ten new OPPG patients presented with phenotypical variability in osseous manifestations."}, {"pubmed": 30513533, "text": "Our data indicate FEVR status is associated with a significantly smaller FAZ, decreased vascular density in the fovea. In addition, patients with the LRP5 mutation had a milder phenotype than those with the FDZ4 or TSPAN12 mutations."}, {"pubmed": 30866603, "text": "LRP5 polymorphism (rs556442) was associated with insulin resistance in Iranian children and adolescents"}, {"pubmed": 31077665, "text": "Molecular diagnosis has been achieved in 7 of 10 families investigated, including a previously unrecognized association with LRP5. WGS enabled molecular diagnosis in 3 families after prior negative Sanger sequencing of the causative gene."}, {"pubmed": 31237656, "text": "The positive rate for pathogenic mutations in the known FEVR-associated genes was 38.9% (21/54). Among the mutations, LRP5 mutation was the predominant, accounting for 66.7% (14/21) of genetic positive patients. Patients with FEVR-RRD due to LRP5 mutations have less retinal vascular leakage or neovasculization than do patients with FEVR-RRD due to TSPAN12/FZD4 mutations."}, {"pubmed": 31405647, "text": "the GG genotype of single nucleotide polymorphism (rs556442) could play protective role in obese women through the association with basal metabolic rate in Iranian postmenopausal women"}, {"pubmed": 31648079, "text": "Combination therapy in the Col1a2(G610C) mouse model of Osteogenesis Imperfecta reveals an additive effect of enhancing LRP5 signaling and inhibiting TGFbeta signaling on trabecular bone but not on cortical bone."}, {"pubmed": 31774873, "text": "LRP5 rs3736228 is associated with lower bone mineral density in postmenopausal osteoporosis."}, {"pubmed": 31881970, "text": "Deletion of low-density lipoprotein-related receptor 5 inhibits liver Cancer cell proliferation via destabilizing Nucleoporin 37."}, {"pubmed": 31957814, "text": "LncRNA LINC00707 promotes osteogenic differentiation of hBMSCs through the Wnt/beta-catenin pathway activated by LINC00707/miR-145/LRP5 axis."}, {"pubmed": 32405501, "text": "A Study of the Relationship between the Polymorphism and Mutation of rs682429 and rs3781590 in the LRP5 Gene and Bone Metabolism in Postmenopausal Type 2 Diabetic Women in Xinjiang."}, {"pubmed": 32991689, "text": "PCSK9 and LRP5 in macrophage lipid internalization and inflammation."}, {"pubmed": 33065966, "text": "TRAP1 Regulates Wnt/beta-Catenin Pathway through LRP5/6 Receptors Expression Modulation."}, {"pubmed": 33101205, "text": "Associations of LRP5 Gene With Bone Mineral Density, Bone Turnover Markers, and Fractures in the Elderly With Osteoporosis."}, {"pubmed": 33118644, "text": "Clinical Phenotype and Relevance of LRP5 and LRP6 Variants in Patients With Early-Onset Osteoporosis (EOOP)."}, {"pubmed": 33136328, "text": "PAR1&2 driven placenta EVT invasion act via LRP5/6 as coreceptors."}, {"pubmed": 33302760, "text": "Novel FZD4 and LRP5 mutations in a small cohort of patients with familial exudative vitreoretinopathy (FEVR)."}, {"pubmed": 33545636, "text": "Distinct roles of LRP5 and LRP6 in Wnt signaling regulation in the retina."}, {"pubmed": 33619830, "text": "Fork-shaped mandibular incisors as a novel phenotype of LRP5-associated disorder."}, {"pubmed": 33939331, "text": "More severe phenotype of early-onset osteoporosis associated with recessive form of LRP5 and combination with DKK1 or WNT3A."}, {"pubmed": 34254535, "text": "Associations between WNT signaling pathway-related gene polymorphisms and risks of osteoporosis development in Chinese postmenopausal women: a case-control study."}, {"pubmed": 34590211, "text": "The genetic polymorphisms of key genes in WNT pathway (LRP5 and AXIN1) was associated with osteoporosis susceptibility in Chinese Han population."}, {"pubmed": 34639175, "text": "Identification of Rare LRP5 Variants in a Cohort of Males with Impaired Bone Mass."}, {"pubmed": 34924743, "text": "Five novel copy number variations detected in patients with familial exudative vitreoretinopathy."}, {"pubmed": 34997691, "text": "LRP5 promotes cancer stem cell traits and chemoresistance in colorectal cancer."}, {"pubmed": 35106624, "text": "Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients' management using bisphosphonates therapy."}, {"pubmed": 35133048, "text": "Heterozygote loss-of-function variants in the LRP5 gene cause familial exudative vitreoretinopathy."}, {"pubmed": 35244470, "text": "Identification of Two Novel Variants in the LRP5 Gene that Cause Familial Exudative Vitreoretinopathy."}, {"pubmed": 35733105, "text": "Association between the LRP5 rs556442 gene polymorphism and the risks of NAFLD and CHD in a Chinese Han population."}, {"pubmed": 35754005, "text": "Mutations in LRP5 and BMP4 are associated with mesiodens, tooth agenesis, root malformation, and oral exostoses."}, {"pubmed": 36018796, "text": "LRP5 BIALLELIC MUTATIONS CAUSE A HIGHER INCIDENCE OF SEVERE PHENOTYPE COMPARED WITH LRP5 MONOALLELIC MUTATION."}, {"pubmed": 36328193, "text": "Single nucleotide polymorphisms (rs3736228 and rs4988321) in low-density lipoprotein receptor-related protein-5 gene with predisposition to rheumatoid arthritis."}, {"pubmed": 36421042, "text": "The relationship between LRP5 rs556442 and rs638051 polymorphisms and mutations and their influence on bone metabolism in postmenopausal Xinjiang women with type 2 diabetes."}, {"pubmed": 36617395, "text": "LDL receptor-related protein 5 rs648438 polymorphism is associated with the risk of skeletal fluorosis."}, {"pubmed": 36720664, "text": "Overexpressions of RHOA, CSNK1A1, DVL2, FZD8, and LRP5 genes enhance gastric cancer development in the presence of Helicobacter pylori."}, {"pubmed": 36947076, "text": "Human Placental LRP5 and Sclerostin are Increased in Gestational Diabetes Mellitus Pregnancies."}, {"pubmed": 37202775, "text": "LRP5-/6 gene polymorphisms and its association with risk of abnormal bone mass in postmenopausal women."}, {"pubmed": 37628576, "text": "LRP5, SLC6A3, and SOX10 Expression in Conventional Ameloblastoma."}, {"pubmed": 37895195, "text": "LRP5, Bone Mass Polymorphisms and Skeletal Disorders."}, {"pubmed": 38030997, "text": "Genetic detection of two novel LRP5 pathogenic variants in patients with familial exudative vitreoretinopathy."}, {"pubmed": 38302983, "text": "Relationship between polymorphisms and mutations at rs7125942 and rs3736228 of LRP5 gene and bone metabolism in postmenopausal women."}, {"pubmed": 38625381, "text": "Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass."}, {"pubmed": 38802968, "text": "Evolutionary and functional analyses of LRP5 in archaic and extant modern humans."}], "genomic_pos": {"chr": "11", "end": 68449275, "ensemblgene": "ENSG00000162337", "start": 68312591, "strand": 1}, "genomic_pos_hg19": {"chr": "11", "end": 68216743, "start": 68080077, "strand": 1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001702", "qualifier": "involved_in", "term": "gastrulation with mouth forming second"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0002053", "pubmed": 17680723, "qualifier": "involved_in", "term": "positive regulation of mesenchymal cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0002076", "qualifier": "involved_in", "term": "osteoblast development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006007", "pubmed": 19673927, "qualifier": "involved_in", "term": "glucose catabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006865", "qualifier": "involved_in", "term": "amino acid transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006897", "qualifier": "involved_in", "term": "endocytosis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007399", "qualifier": "involved_in", "term": "nervous system development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008078", "qualifier": "involved_in", "term": "mesodermal cell migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008203", "qualifier": "involved_in", "term": "cholesterol metabolic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0008217", "pubmed": 18721193, "qualifier": "involved_in", "term": "regulation of blood pressure"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0008284", "pubmed": 9790987, "qualifier": "involved_in", "term": "positive regulation of cell population proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009952", "qualifier": "involved_in", "term": "anterior/posterior pattern specification"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010467", "qualifier": "involved_in", "term": "gene expression"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0033687", "qualifier": "involved_in", "term": "osteoblast proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0033690", "qualifier": "involved_in", "term": "positive regulation of osteoblast proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035019", "qualifier": "involved_in", "term": "somatic stem cell population maintenance"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035426", "qualifier": "involved_in", "term": "extracellular matrix-cell signaling"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042074", "qualifier": "involved_in", "term": "cell migration involved in gastrulation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0042632", "pubmed": [18721193, 20146170], "qualifier": "involved_in", "term": "cholesterol homeostasis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042733", "qualifier": "involved_in", "term": "embryonic digit morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042981", "qualifier": "involved_in", "term": "regulation of apoptotic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043434", "qualifier": "involved_in", "term": "response to peptide hormone"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045600", "pubmed": 17680723, "qualifier": "involved_in", "term": "positive regulation of fat cell differentiation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045668", "pubmed": 17680723, "qualifier": "involved_in", "term": "negative regulation of osteoblast differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045669", "qualifier": "involved_in", "term": "positive regulation of osteoblast differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045840", "pubmed": 9790987, "qualifier": "involved_in", "term": "positive regulation of mitotic nuclear division"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045893", "pubmed": [15035989, 17955262], "qualifier": "involved_in", "term": "positive regulation of DNA-templated transcription"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": 12857724, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0046849", "qualifier": "involved_in", "term": "bone remodeling"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0048539", "pubmed": 17680723, "qualifier": "involved_in", "term": "bone marrow development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060033", "qualifier": "involved_in", "term": "anatomical structure regression"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0060042", "pubmed": 15346351, "qualifier": "involved_in", "term": "retina morphogenesis in camera-type eye"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0060070", "qualifier": "involved_in", "term": "canonical Wnt signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0060070", "pubmed": [11029007, 12121999, 12857724, 15908424, 24706814, 25920554], "qualifier": "involved_in", "term": "canonical Wnt signaling pathway"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0060070", "pubmed": [11336703, 16805831], "qualifier": "involved_in", "term": "canonical Wnt signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0060070", "pubmed": [18044981, 19673927], "qualifier": "involved_in", "term": "canonical Wnt signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0060349", "pubmed": [19673927, 20146170, 20630166], "qualifier": "involved_in", "term": "bone morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060444", "qualifier": "involved_in", "term": "branching involved in mammary gland duct morphogenesis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0060612", "pubmed": 17680723, "qualifier": "involved_in", "term": "adipose tissue development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060764", "qualifier": "involved_in", "term": "cell-cell signaling involved in mammary gland development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060856", "qualifier": "involved_in", "term": "establishment of blood-brain barrier"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0061178", "qualifier": "involved_in", "term": "regulation of insulin secretion involved in cellular response to glucose stimulus"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0061304", "pubmed": [15024691, 15346351], "qualifier": "involved_in", "term": "retinal blood vessel morphogenesis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0071901", "pubmed": 19107203, "qualifier": "involved_in", "term": "negative regulation of protein serine/threonine kinase activity"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0098609", "qualifier": "involved_in", "term": "cell-cell adhesion"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0110135", "pubmed": [15035989, 17955262], "qualifier": "involved_in", "term": "Norrin signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1902262", "qualifier": "involved_in", "term": "apoptotic process involved in blood vessel morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1990963", "qualifier": "involved_in", "term": "establishment of blood-retinal barrier"}], "CC": [{"evidence": "IEA", "gocategory": "CC", "id": "GO:0005783", "qualifier": "located_in", "term": "endoplasmic reticulum"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 17680723, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0043235", "pubmed": 18762581, "qualifier": "part_of", "term": "receptor complex"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:1990851", "pubmed": [20093360, 22988876], "qualifier": "part_of", "term": "Wnt-Frizzled-LRP5/6 complex"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:1990909", "pubmed": 24115276, "qualifier": "part_of", "term": "Wnt signalosome"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [11336703, 11433302, 15908424, 18762581, 20393562, 21471202, 28514442], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0015026", "pubmed": 11336703, "qualifier": "enables", "term": "coreceptor activity"}, {"category": "MF", "evidence": "NAS", "id": "GO:0015026", "pubmed": 24431302, "qualifier": "enables", "term": "coreceptor activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0017147", "qualifier": "enables", "term": "Wnt-protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0017147", "pubmed": 11336703, "qualifier": "enables", "term": "Wnt-protein binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0017147", "qualifier": "enables", "term": "Wnt-protein binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0017147", "pubmed": 22988876, "qualifier": "enables", "term": "Wnt-protein binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0019534", "pubmed": 18350154, "qualifier": "NOT enables", "term": "toxin transmembrane transporter activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0042813", "qualifier": "enables", "term": "Wnt receptor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0042813", "pubmed": [24706814, 25920554], "qualifier": "enables", "term": "Wnt receptor activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0042813", "qualifier": "enables", "term": "Wnt receptor activity"}]}, "homologene": {"genes": [[7955, 568518], [8364, 100491803], [9031, 423114], [9598, 451380], [9606, 4041], [9615, 100306933], [9913, 534450], [10090, 16973], [10116, 293649]], "id": 1746}, "interpro": [{"desc": "LDLR class B repeat", "id": "IPR000033", "short_desc": "LDLR_classB_rpt"}, {"desc": "EGF-like domain", "id": "IPR000742", "short_desc": "EGF-like_dom"}, {"desc": "Low-density lipoprotein (LDL) receptor class A repeat", "id": "IPR002172", "short_desc": "LDrepeatLR_classA_rpt"}, {"desc": "Six-bladed beta-propeller, TolB-like", "id": "IPR011042", "short_desc": "6-blade_b-propeller_TolB-like"}, {"desc": "Low density lipoprotein receptor-related protein 5/6", "id": "IPR017049", "short_desc": "LRP5/6"}, {"desc": "Low-density lipoprotein (LDL) receptor class A, conserved site", "id": "IPR023415", "short_desc": "LDLR_class-A_CS"}, {"desc": "LDL receptor-like superfamily", "id": "IPR036055", "short_desc": "LDL_receptor-like_sf"}], "ipi": ["IPI00744811", "IPI00980932"], "map_location": "11q13.2", "name": "LDL receptor related protein 5", "other_names": ["low density lipoprotein receptor-related protein 5", "low density lipoprotein receptor-related protein 7", "low-density lipoprotein receptor-related protein 5"], "pantherdb": {"HGNC": "6697", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1278315", "ortholog_type": "LDO", "panther_family": "PTHR46513", "taxid": 10090, "uniprot_kb": "Q91VN0"}, {"RGD": "1309329", "ortholog_type": "LDO", "panther_family": "PTHR46513", "taxid": 10116, "uniprot_kb": "F1MAD0"}, {"ZFIN": "ZDB-GENE-050518-2", "ortholog_type": "LDO", "panther_family": "PTHR46513", "taxid": 7955, "uniprot_kb": "F1QTJ4"}, {"FlyBase": "FBgn0000119", "ortholog_type": "O", "panther_family": "PTHR46513", "taxid": 7227, "uniprot_kb": "A1Z9D7"}], "uniprot_kb": "O75197"}, "pathway": {"kegg": [{"id": "hsa04150", "name": "mTOR signaling pathway - Homo sapiens (human)"}, {"id": "hsa04310", "name": "Wnt signaling pathway - Homo sapiens (human)"}, {"id": "hsa04928", "name": "Parathyroid hormone synthesis, secretion and action - Homo sapiens (human)"}, {"id": "hsa05010", "name": "Alzheimer disease - Homo sapiens (human)"}, {"id": "hsa05022", "name": "Pathways of neurodegeneration - multiple diseases - Homo sapiens (human)"}, {"id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)"}, {"id": "hsa05224", "name": "Breast cancer - Homo sapiens (human)"}, {"id": "hsa05225", "name": "Hepatocellular carcinoma - Homo sapiens (human)"}, {"id": "hsa05226", "name": "Gastric cancer - Homo sapiens (human)"}], "netpath": {"id": "Pathway_Wnt", "name": "Wnt"}, "pid": [{"id": "ncadherinpathway", "name": "N-cadherin signaling events"}, {"id": "wnt_signaling_pathway", "name": "Wnt signaling network"}], "reactome": [{"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-195721", "name": "Signaling by WNT"}, {"id": "R-HSA-195721", "name": "Signaling by WNT"}, {"id": "R-HSA-201681", "name": "TCF dependent signaling in response to WNT"}, {"id": "R-HSA-201681", "name": "TCF dependent signaling in response to WNT"}, {"id": "R-HSA-3772470", "name": "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"}, {"id": "R-HSA-4641262", "name": "Disassembly of the destruction complex and recruitment of AXIN to the membrane"}, {"id": "R-HSA-4641262", "name": "Disassembly of the destruction complex and recruitment of AXIN to the membrane"}, {"id": "R-HSA-4641263", "name": "Regulation of FZD by ubiquitination"}, {"id": "R-HSA-4791275", "name": "Signaling by WNT in cancer"}, {"id": "R-HSA-5339717", "name": "Signaling by LRP5 mutants "}, {"id": "R-HSA-5340588", "name": "Signaling by RNF43 mutants"}, {"id": "R-HSA-5663202", "name": "Diseases of signal transduction by growth factor receptors and second messengers"}], "wikipathways": [{"id": "WP1544", "name": "MicroRNAs in cardiomyocyte hypertrophy"}, {"id": "WP2572", "name": "Primary focal segmental glomerulosclerosis (FSGS)"}, {"id": "WP2877", "name": "Vitamin D Receptor Pathway"}, {"id": "WP363", "name": "Wnt Signaling Pathway"}, {"id": "WP3658", "name": "Wnt-beta-catenin signaling pathway in leukemia"}, {"id": "WP3931", "name": "ESC Pluripotency Pathways"}, {"id": "WP399", "name": "Wnt signaling pathway and pluripotency"}, {"id": "WP4150", "name": "Wnt signaling in kidney disease"}, {"id": "WP4239", "name": "Epithelial to mesenchymal transition in colorectal cancer"}, {"id": "WP4258", "name": "LncRNA involvement in canonical Wnt signaling and colorectal cancer"}, {"id": "WP4262", "name": "Breast cancer pathway"}, {"id": "WP428", "name": "Wnt signaling"}, {"id": "WP4336", "name": "ncRNAs involved in Wnt signaling in hepatocellular carcinoma"}, {"id": "WP4786", "name": "Type I collagen synthesis in the context of Osteogenesis imperfecta"}, {"id": "WP4787", "name": "Osteoblast differentiation"}]}, "pfam": ["PF00057", "PF00058", "PF14670"], "pharmgkb": "PA30455", "pharos": {"target_id": 8656, "tdl": "Tbio"}, "pir": "JE0372", "prosite": ["PS50068", "PS51120"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF252291", "relationship": "is"}, {"id": "GNF252292", "relationship": "is"}, {"id": "GNF252293", "relationship": "is"}, {"id": "GNF252294", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF046421", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF085622", "relationship": "is"}, {"id": "GNF085623", "relationship": "is"}, {"id": "GNF085624", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF052329", "relationship": "is"}, {"id": "GNF057099", "relationship": "is"}, {"id": "GNF061946", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070301", "relationship": "is"}, {"id": "GNF070302", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF095415", "relationship": "is"}, {"id": "GNF135072", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000011.10", "NC_060935.1", "NG_015835.3"], "protein": ["NP_001278831.1", "NP_002326.2", "XP_005274051.1", "XP_011543331.1", "XP_011543332.1", "XP_011543333.1", "XP_016873224.1", "XP_016873225.1", "XP_047282904.1", "XP_047282905.1", "XP_047282906.1", "XP_054224760.1", "XP_054224761.1", "XP_054224762.1", "XP_054224763.1", "XP_054224764.1", "XP_054224765.1", "XP_054224766.1", "XP_054224767.1", "XP_054224768.1"], "rna": ["NM_001291902.2", "NM_002335.4", "XM_005273994.3", "XM_011545029.2", "XM_011545030.2", "XM_011545031.2", "XM_017017735.2", "XM_017017736.2", "XM_047426948.1", "XM_047426949.1", "XM_047426950.1", "XM_054368785.1", "XM_054368786.1", "XM_054368787.1", "XM_054368788.1", "XM_054368789.1", "XM_054368790.1", "XM_054368791.1", "XM_054368792.1", "XM_054368793.1", "XR_001747874.2"], "translation": [{"protein": "XP_054224761.1", "rna": "XM_054368786.1"}, {"protein": "XP_047282904.1", "rna": "XM_047426948.1"}, {"protein": "XP_047282905.1", "rna": "XM_047426949.1"}, {"protein": "NP_002326.2", "rna": "NM_002335.4"}, {"protein": "XP_054224765.1", "rna": "XM_054368790.1"}, {"protein": "XP_011543331.1", "rna": "XM_011545029.2"}, {"protein": "XP_016873225.1", "rna": "XM_017017736.2"}, {"protein": "NP_001278831.1", "rna": "NM_001291902.2"}, {"protein": "XP_054224767.1", "rna": "XM_054368792.1"}, {"protein": "XP_005274051.1", "rna": "XM_005273994.3"}, {"protein": "XP_054224764.1", "rna": "XM_054368789.1"}, {"protein": "XP_054224763.1", "rna": "XM_054368788.1"}, {"protein": "XP_054224760.1", "rna": "XM_054368785.1"}, {"protein": "XP_011543332.1", "rna": "XM_011545030.2"}, {"protein": "XP_054224766.1", "rna": "XM_054368791.1"}, {"protein": "XP_047282906.1", "rna": "XM_047426950.1"}, {"protein": "XP_016873224.1", "rna": "XM_017017735.2"}, {"protein": "XP_054224762.1", "rna": "XM_054368787.1"}, {"protein": "XP_054224768.1", "rna": "XM_054368793.1"}, {"protein": "XP_011543333.1", "rna": "XM_011545031.2"}]}, "reporter": {"HG-U133_Plus_2": ["209468_at", "229591_at"], "HG-U95Av2": "41831_at", "HTA-2_0": "TC11000707.hg.1", "HuEx-1_0": ["3337516", "3955627"], "HuGene-1_1": "7942007", "HuGene-2_1": "16728066"}, "retired": [4039, 4984, 8058], "summary": "This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014].", "symbol": "LRP5", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1416917"}, "unigene": "Hs.6347", "uniprot": {"Swiss-Prot": "O75197", "TrEMBL": ["H0YE98", "E9PHY1"]}, "wikipedia": {"url_stub": "LRP5"}}